Actinogen

Gain a direct line to Actinogen leadership

Be first to know our latest company updates

Watch exclusive videos accompanying major news

Webinars

General Meeting

Financial Calendar

Right to Receive Documents

Annual General Meeting

Investor Contacts

FAQs

Shareholders

Analyst Research

Announcements

Financial Results

Annual Reports

Corporate Presentations

Investors

Home

Invest

Share Price

US Newswires

Company Updates

Australian News

News

Inter

Investor Hub

View the company's US newswire published 28 May 2026

https://www.globenewswire.com/news-release/2026/05/28/3302808/0/en/actinogen-receives-positive-ema-scientific-advice-aligned-with-prior-fda-guidance-for-its-alzheimer-s-disease-program.html

ACW receives positive EMA scientific advice aligned with prior FDA guidance for its AD program